These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25903418)

  • 1. Incretins.
    Wu T; Rayner CK; Horowitz M
    Handb Exp Pharmacol; 2016; 233():137-71. PubMed ID: 25903418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incretin hormones: Their role in health and disease.
    Nauck MA; Meier JJ
    Diabetes Obes Metab; 2018 Feb; 20 Suppl 1():5-21. PubMed ID: 29364588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incretin system and its role in type 2 diabetes mellitus.
    Holst JJ; Vilsbøll T; Deacon CF
    Mol Cell Endocrinol; 2009 Jan; 297(1-2):127-36. PubMed ID: 18786605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evolving story of incretins (GIP and GLP-1) in metabolic and cardiovascular disease: A pathophysiological update.
    Nauck MA; Quast DR; Wefers J; Pfeiffer AFH
    Diabetes Obes Metab; 2021 Sep; 23 Suppl 3():5-29. PubMed ID: 34310013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiology of incretins and loss of incretin effect in type 2 diabetes and obesity.
    Opinto G; Natalicchio A; Marchetti P
    Arch Physiol Biochem; 2013 Oct; 119(4):170-8. PubMed ID: 23859800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Incretin hormones in the treatment of type 2 diabetes. Part I: influence of insulinotropic gut-derived hormones (incretins) on glucose metabolism].
    Matuszek B; Lenart-Lipińska M; Nowakowski A
    Endokrynol Pol; 2007; 58(6):522-8. PubMed ID: 18205109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of Glucose-dependent Insulinotropic Polypeptide (GIP) on human adipose tissue and fat metabolism: Implications for obesity, type 2 diabetes and Non-Alcoholic Fatty Liver Disease (NAFLD).
    Thondam SK; Cuthbertson DJ; Wilding JPH
    Peptides; 2020 Mar; 125():170208. PubMed ID: 31759125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RD Lawrence Lecture 2017 Incretins: the intelligent hormones in diabetes.
    Gault VA
    Diabet Med; 2018 Jan; 35(1):33-40. PubMed ID: 29044772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging incretin hormones actions: focus on bone metabolism.
    Grammatiki M; Antonopoulou V; Kotsa K
    Minerva Endocrinol; 2019 Sep; 44(3):264-272. PubMed ID: 30991794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mining incretin hormone pathways for novel therapies.
    Wideman RD; Kieffer TJ
    Trends Endocrinol Metab; 2009 Aug; 20(6):280-6. PubMed ID: 19595611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New physiological effects of the incretin hormones GLP-1 and GIP.
    Asmar M
    Dan Med Bull; 2011 Feb; 58(2):B4248. PubMed ID: 21299928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incretins: from the concept to their use in the treatment of type 2 diabetes. Part A: incretins: concept and physiological functions.
    Girard J
    Diabetes Metab; 2008 Dec; 34(6 Pt 1):550-9. PubMed ID: 19036624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The contribution of incretin hormones to the pathogenesis of type 2 diabetes.
    Meier JJ
    Best Pract Res Clin Endocrinol Metab; 2009 Aug; 23(4):433-41. PubMed ID: 19748061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiology of incretins in health and disease.
    Deacon CF; Ahrén B
    Rev Diabet Stud; 2011; 8(3):293-306. PubMed ID: 22262068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incretins in obesity and diabetes.
    Chia CW; Egan JM
    Ann N Y Acad Sci; 2020 Feb; 1461(1):104-126. PubMed ID: 31392745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.
    Theodorakis MJ; Carlson O; Michopoulos S; Doyle ME; Juhaszova M; Petraki K; Egan JM
    Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E550-9. PubMed ID: 16219666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a place for incretin therapies in obesity and prediabetes?
    Holst JJ; Deacon CF
    Trends Endocrinol Metab; 2013 Mar; 24(3):145-52. PubMed ID: 23415157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The concept of incretins and the physiological roles of incretins].
    Kawamori R
    Nihon Rinsho; 2011 May; 69(5):761-9. PubMed ID: 21595259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The entero-insular axis in type 2 diabetes--incretins as therapeutic agents.
    Creutzfeldt W
    Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S288-303. PubMed ID: 11460578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon-like peptides 1 and 2 in health and disease: a review.
    Marathe CS; Rayner CK; Jones KL; Horowitz M
    Peptides; 2013 Jun; 44():75-86. PubMed ID: 23523778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.